In Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 June 4, 2025 No Comments Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Offer Booklet – Non-Renounceable Entitlement Offer June 6, 2025 Justin Huhn: Uranium Game On — Supply “Mirage,” De-risked Demand, Next Price Move June 6, 2025 Should You Invest in Silver Bullion? June 6, 2025